Idaho Center for Reproductive Medicine

Cristin Coulam Slater, M.D
Curriculum Vitae

EDUCATION

[ Back to top ]

LICENSURE

California             #G81581
Retired license / Expiration date:  10/31/2006
Idaho                     #M-8614
Expiration date:  6/30/09
Idaho Pharmacy   #CS9638
Expiration date: 12/31/07
Utah                     #6194181-1205
Utah Controlled Substance  #6194181-8905
Expiration date:  1/31/10
DEA                    #BC4536201
Expiration date:  08/31/2010

[ Back to top ]

BOARD CERTIFICATIONS

The American Board of Obstetrics and
Gynecology, Inc., Board certified #971040

The American Board of Obstetrics and
Gynecology, Inc., Division of Reproductive
Endocrinology and Infertility, Board certified

[ Back to top ]

PROFESSIONAL BACKGROUND

08/05/02 – current                                                             Reproductive Endocrinologist
Idaho Center for Reproductive Medicine
111 Main Street, suite #100
       Boise, Idaho 83712

07/01/99 – 07/26/02                                     Assistant Professor of Clinical Obstetrics and
Gynecology
Keck School of Medicine of the
University of Southern California
Los Angeles, California

[ Back to top ]

TEACHING RESPONSIBILITIES

[ Back to top ]

ADMINISTRATIVE RESPONSIBILITIES

[ Back to top ]

HOSPITAL AFFILIATIONS

[ Back to top ]

AD HOC EDITORIAL BOARD

[ Back to top ]

SOCIAET MEMBERSHIPS

[ Back to top ]

AWARDS

[ Back to top ]

GRANTS

  1. Title: A multicenter, randomized, open-label, parallel group study to evaluate the endometrial safety following treatment with ORTHO-PREFESTâ compared to PREMPROä in overweight menopausal women.

    Sponsor: Ortho-McNeil Pharmaceuticals, Inc.

    Amount: $49,710.00

    Period: June, 2001 – August, 2002
  2. Title: A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of a continuous-combined HRT preparation containing 1 mg estradiol and 3 mg drospirenone on blood pressure in mildly hypertensive postmenopausal women

    Sponsor: Berlex Laboratories, Inc.

    Grant period: 2001

    Amount:  $116,844

[ Back to top ]

LIST OF PUBLICATIONS

Peer-Review Journals:

[ Back to top ]

CHAPTERS

  1. Slater CC, Shoupe D.  Polycystic ovarian syndrome.  In:  Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 364-7, 2002.  Blackwell Science, Inc., Malden, Massachusetts
  2. Slater CC.  Tubal factor infertility.  In:  Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 406-8, 2002.  Blackwell Science, Inc., Malden, Massachusetts.
  3. Slater CC.  Tubal factor infertility:  Treatment.  In:  Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 409-10, 2002.  Blackwell Science, Inc., Malden, Massachusetts.

[ Back to top ]

ABSTRACTS

  1. Coulam C, Acacio BD, Patel SK, Mack WJ, Hodis HN, Mistry JS, Ranadive GN, Savjani G, Shoupe D, Paulson RJ, Stanczyk FZ.  Accumulation of estrone sulfate following long-term oral and transdermal administration of estradiol in postmenopausal women.  Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.

  2. Coulam C, Gray JD, Gentzschein E, Paulson RJ, Stanczyk FZ.  Effects of oral estrogen replacement on cytokine production in post-menopausal women.  Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.

  3. Coulam C, Chang L, Zhang C, Jacob CO, Stanczyk FZ.  Is 17-hydroxylase/C17,20-lase activity impaired in patients with systemic lupus erythematous?  Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.

  4. Coulam C, Chang L, Paulson RJ, Stanczyk FZ.  Altered balance between the 5a-reductase and aromatase pathways during ovarian stimulation with HMG.  Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.

  5. Cho MM, Coulam C, Stanczyk FZ, Paulson RJ.  The ovarian contribution to serum levels of vascular endothelial growth factor during stimulated cycles.  Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.

  6. Bello SM, Gray JD, Navidazeh N, Gentzschein E, Coulam C, Shoupe D, Stanczyk FZ.  Effects of oral and transdermal estradiol on the growth hormone/IGF-1 axis in relation to the immune system.  Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.

  7. Coulam C, Chang L, Stanczyk FZ, Paulson RJ.  Comparison of 5a-reductase and aromatase pathways during ovarian stimulation with different gonadotropic formulations.  Presented at the joint meeting of the 16th World Congress on Fertility and Sterility and the 54th Annual Meeting of The American Society for Reproductive Medicine, IFFS’98, October 4-9, 1998, San Francisco, California.

  8. Coulam C, Stanczyk FZ, Gray JD, Ramos DE, Paulson RJ, Roy S.  DHEA modulates cytokine production in post-menopausal women.  Presented at the 46th Annual Meeting of the Society for Gynecologic Investigation, March 10-13, 1999, Atlanta, Georgia.

  9. Coulam C, Stanczyk FZ, Paulson RJ.  Estrone sulfate as a predictor of gonadotropin response during controlled ovarian hyperstimulation (COH).  Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.

  10. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ.  Vaginal administration of estradiol in preparation for oocyte donation.  Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.

  11. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ.  Vaginal administration of oestradiol in preparation for oocyte donation.  Presented at the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, June 26-30, 1999, Tours, France.

  12. Coulam C, Acacio BD, Hodis HN, Paulson RJ, Stanczyk FZ.  Correlation between plasma estradiol (E2) and estrone sulfate (E1-S) levels following long-term oral and transdermal administration of estradiol in healthy postmenopausal women (PMW).  Presented at the Conjoint Annual Meeting of The American Society for Reproductive Medicine (55th) and the Canadian Fertility and Andrology Society, September 25-30, 1999, Toronto, Ontario, Canada.

  13. Slater CC, Zhang C, Shoupe D, Paulson RJ, Xiang M, Mack W, Hodis H, Stanczyk FZ.  Low free testosterone and excessive estrogen levels in serum during 3 years of treatment with oral estradiol in postmenopausal women.  Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.

  14. Slater CC, Zhang C, Guan C, Huang R, Paulson RJ, Roy S, Stanczyk FZ.  Dihydrotestosterone (DHT) accumulation as a consequence of long-term DHEA supplementation in postmenopausal women.  Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

  15. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ.  Blastocyst transfer is associated with an increased rate of monozygotic twins.  Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

  16. Slater C, Souter I, Stanczyk F, Mishell DR Jr.  Postmenopausal testosterone replacement via gel and lozenge form.  Presented at the annual meeting of The American College of Obstetricians and Gynecologists, Districts VIII and IX, August 4-6, 2000, Anchorage, Alaska.

  17. Parks KS, Stanczyk FZ, Slater CC, Zhang C, Guan C, Mishell DR Jr.  Androgen levels before and after prophylactic oophorectomy.  Presented at the annual meeting of The American College of Obstetricians and Gynecologists, Districts VIII and IX, August 4-6, 2000, Anchorage, Alaska.

  18. Slater C, Shoupe D, Mack WJ, Lobo RA, Hodis HN.  Subclinical atherosclerosis is elevated in oophorectomized healthy postmenopausal women (PMW).  Presented at the 56th Annual Meeting of The American Society for Reproductive Medicine, October 21-26, 2000, San Diego, California.

  19. Parks KS, Stanczyk FZ, Slater CC, Zhang C, Guan C, Mishell DR Jr.  Androgen levels before and after prophylactic oophorectomy.  Presented at the 67th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, November 14-19, 2000, Kamuela, Hawaii.
  20. Jain JK, Slater CC, Francis MM, Paulson RJ.  Monozygotic triplets following blastocyst transfer.  Presented at the 8th World Congress of Gynecological Endocrinology, December 6-9, 2000, Florence, Italy.

  21. Slater C, Zhang C, Guan C, Paulson RJ, Roy S, Stanczyk FZ.  Potential use of DHEA supplementation for estrogen and androgen replacement in postmenopausal women.  Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14-17, 2001, Toronto, Ontario, Canada.

  22. Slater CC, Souter I, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.  Pharmacokinetics of postmenopausal testosterone replacement following percutaneous gel or buccal administration.  Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14-17, 2001, Toronto, Ontario, Canada.

  23. Slater CC, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.  Excessive serum testosterone levels are found during testosterone replacement therapy in postmenopausal women.  Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  24. Slater CC, Shoupe D, Mack WJ, Stanczyk FZ, Hodis HN.  Evaluation of baseline carotid artery intima-media thickness and its progression over two years in postmenopausal women with and without intact ovaries.  Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  25. Slater CC, Parks KS, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.  Androgen levels prior to, and following prophylactic oophorectomy.  Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  26. Saadat P, Slater CC, Patel S, Jain JK, Stanczyk FZ, Paulson RJ.  Very high FSH levels do not result in additional follicular development in poor responders to ovarian stimulation.  Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  27. Boostanfar R, Sorensen L, Ambroggio J, Jain JK, Slater CC, Francis MM, Paulson RJ.  Pregnancy outcome in women 50 or more years of age:  A decade of experience.  Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  28. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ.  The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system.  Presented at the 17th Annual Meeting of the European Society of Human Reproduction and Embryology, July 1-4, 2001, Lausanne, Switzerland.

  29. Boostanfar R, Campeau JD, Saadat P, Tourgeman DE, Slater CC, Jain JK, diZerega GS, Kobak WH.  Use of the Harmonic Scapelâ as a novel technique for distal neosalpingostomy.  Presented at the 30th Annual Meeting of the American Association of Gynecologic Laparoscopists, November 16-19, 2001, San Francisco, California.
  31. Slater CC, Parks KS, Paulson RJ, Stanczyk FZ, Mishell DR Jr.  Androgen levels before and after bilateral oophorectomy.  Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.
  32. Saadat P, Mor E, Slater CC, Stanczyk FZ, Paulson RJ, Shoupe D, Hodis HN, Mack WJ.  Postmenopausal oral estrogen replacement therapy and changes in blood pressure:  A randomized placebo-controlled trial.  Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

  33. Boostanfar R, Slater C, Klumph S, Saadat P, Tourgeman D, Paulson RJ.  Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation:  Impact of GnRH agonist vs. antagonist.  Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

  34. Mor E, Saadat P, Zhang C, Stanczyk FZ, Slater CC, Jain J, Tourgeman D, Paulson RJ.  Ovarian and adrenal androgen profiles in cycles of controlled ovarian hyperstimulation utilizing GnRH antagonists or agonists.  Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

[ Back to top ]